Please login to the form below

Not currently logged in
Email:
Password:

Westminster Advisers expands health practice

Sarah Gullo and Emily Cameron join public affairs specialist agency

London-based Westminster Advisers has expanded its health practice, WA Health, with the appointment of two new associate directors to its team.

Sarah Gullo joins the public affairs specialist agency from Verve Communications, where she had served as a senior communications consultant since 2013.

Gullo brings over a decade of experience in political campaigning and communications advisory roles from both Australia and the UK, which includes working with NHS trusts and leading media relations for reform agenda on behalf of the Queensland government.

Meanwhile, also moving to WA Health is Emily Cameron who previously worked in life sciences minister George Freeman's parliamentary office as chief of staff and communications lead.

Prior to this, Cameron served as Whizz-Kidz's public affairs and campaigns manager, and also brings experience from Hanover Communications, The Health Foundation, and Gorkana.

Dominic Church, managing director at Westminster Advisers, said: “I'm delighted to welcome Emily and Sarah to Westminster Advisers.

“We're already proud of our health offer, and these hires further highlight our capability and capacity to deliver across the spectrum in healthcare communications, with a real strength in depth of knowledge and experience across the consultancy team.”

11th July 2016

From: Marketing

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Thrive Agency

We are a specialist health communication agency creating powerful and trusted content. If you’re looking for a partner to help...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...